New patent for Chemocentryx drug TAVNEOS

Annual Drug Patent Expirations for TAVNEOS Tavneos is a drug marketed by Chemocentryx and is included in one NDA. It is available from one supplier. There are three patents protecting…

Source


Comments are closed.

Biotechblog